Novartis Access
Launched in September 2015, Novartis Access is an unprecedented new Novartis-wide initiative to drive patient access to our medicines in lower-income countries. It is the latest addition to our ongoing efforts to enhance access to affordable, high-quality healthcare for patients at every level of the income pyramid.
The Novartis Access program, which is operated by Sandoz, focuses on affordability and availability of targeted on- and off-patent medicines addressing key non-communicable diseases (NCDs) – cardiovascular disease, diabetes, respiratory illnesses and breast cancer. Its portfolio of 15 medicines, many of which are Sandoz products, is provided to governments, NGOs and other public-sector customers at a price of USD 1 per treatment per month.
How much do you know about noncommunicable diseases? How are they impacting developing nations? Test your knowledge with a short quiz.
